[Form 4] VolitionRX Limited Insider Trading Activity
VolitionRX Ltd. (VNRX) reporting person Ann-Louise Batchelor was awarded 27,400 restricted stock units (RSUs) on 08/15/2025 under the companys 2015 Stock Incentive Plan in lieu of cash compensation. The RSUs are earned in six approximately equal monthly installments beginning 09/01/2025 and, once earned, remain subject to additional time-based vesting in two equal installments of 13,700 units on 11/01/2025 and 02/01/2026. Upon vesting and settlement each RSU converts into one share of common stock. The filing reports 159,886 shares beneficially owned directly after the transaction and 29,406 shares held indirectly by spouse. The award is conditioned on continued service through the applicable earning and vesting dates.
VolitionRX Ltd. (VNRX): la reporting person Ann-Louise Batchelor ha ricevuto 27.400 unit脿 azionarie vincolate (RSU) il 15/08/2025 nell鈥檃mbito del Piano di Incentivazione Azionaria 2015 della societ脿 in sostituzione di compensi in contanti. Le RSU vengono maturate in sei rate mensili approssimativamente uguali a partire dal 01/09/2025 e, una volta maturate, sono soggette a un ulteriore periodo di vesting basato sul tempo, suddiviso in due rate uguali di 13.700 unit脿 rispettivamente il 01/11/2025 e il 01/02/2026. Al momento del vesting e del regolamento, ogni RSU si converte in una azione ordinaria. Il documento dichiara il possesso diretto di 159.886 azioni subito dopo la transazione e 29.406 azioni detenute indirettamente dal coniuge. L鈥檃ssegnazione 猫 subordinata alla prosecuzione del servizio fino alle date previste per maturazione e vesting.
VolitionRX Ltd. (VNRX): la persona informante Ann-Louise Batchelor recibi贸 27.400 unidades restringidas de acciones (RSU) el 15/08/2025 bajo el Plan de Incentivos de Acciones 2015 de la compa帽铆a, en lugar de una remuneraci贸n en efectivo. Las RSU se devengar谩n en seis cuotas mensuales aproximadamente iguales a partir del 01/09/2025 y, una vez devengadas, estar谩n sujetas a un vesting adicional por tiempo en dos cuotas iguales de 13.700 unidades el 01/11/2025 y el 01/02/2026. Al vencimiento y liquidaci贸n, cada RSU se convierte en una acci贸n ordinaria. La presentaci贸n informa la tenencia directa de 159.886 acciones inmediatamente despu茅s de la operaci贸n y 29.406 acciones mantenidas indirectamente por el c贸nyuge. La concesi贸n est谩 condicionada a la continuidad del servicio hasta las fechas de devengo y vesting aplicables.
VolitionRX Ltd. (VNRX)鞚� 氤搓碃鞛� Ann-Louise Batchelor電� 2025雲� 8鞗� 15鞚� 須岇偓鞚� 2015 欤检嫕 鞚胳劶韹半笇 頂岆灉鞐� 霐半澕 順勱笀 氤挫垬 雽�鞁� 27,400 鞝滍暅欤�(RSU)毳� 靾橃棳氚涭晿鞀惦媹雼�. 頃措嫻 RSU電� 2025雲� 9鞗� 1鞚茧秬韯� 鞎� 鞐劘 臧滌潣 霃欖澕頃� 鞗旊硠 攵勴暊搿� 旆摑霅橂┌, 旆摑 鞚错泟鞐愲姅 於旉皜鞝侅澑 旮瓣皠 旮半皹 氩犾姢韺呾澊 鞝侅毄霅橃柎 2025雲� 11鞗� 1鞚缄臣 2026雲� 2鞗� 1鞚� 臧侁皝 13,700 雼渼鞌� 霊� 氩堨棎 瓯胳硱 頇曥爼霅╇媹雼�. 氩犾姢韺� 氚� 鞝曥偘 鞁� 臧� RSU電� 氤错喌欤� 1欤茧 鞝勴櫂霅╇媹雼�. 鞝滌稖靹滊鞐愲姅 瓯半灅 歆來泟 歆侅爲 氤挫湢頃� 159,886欤�鞕� 氚办毎鞛愱皜 臧勳爲 氤挫湢頃� 29,406欤�臧� 氤搓碃霅橃柎 鞛堨姷雼堧嫟. 鞚� 靾橃棳電� 頃措嫻 旆摑 氚� 氩犾姢韺� 雮犾旯岇 瓿勳啀 攴茧頃橂姅 瓴冹潉 臁瓣贝鞙茧 頃╇媹雼�.
VolitionRX Ltd. (VNRX) : la personne d茅clarante Ann-Louise Batchelor s鈥檈st vue attribuer 27 400 unit茅s d鈥檃ctions restreintes (RSU) le 15/08/2025 dans le cadre du Plan d鈥檌ncitation en actions 2015 de la soci茅t茅, en lieu et place d鈥檜ne r茅mun茅ration en esp猫ces. Les RSU sont acquises en six versements mensuels 脿 peu pr猫s 茅gaux 脿 compter du 01/09/2025 et, une fois acquises, sont soumises 脿 un vesting suppl茅mentaire bas茅 sur la dur茅e, en deux versements 茅gaux de 13 700 unit茅s les 01/11/2025 et 01/02/2026. Lors du vesting et du r猫glement, chaque RSU se convertit en une action ordinaire. Le dossier indique une d茅tention directe de 159 886 actions imm茅diatement apr猫s la transaction et 29 406 actions d茅tenues indirectement par le conjoint. L鈥檃ttribution est conditionn茅e 脿 la poursuite du service jusqu鈥檃ux dates d鈥檃cquisition et de vesting applicables.
VolitionRX Ltd. (VNRX): Die meldende Person Ann-Louise Batchelor wurde am 15.08.2025 im Rahmen des Aktienanreizprogramms 2015 der Gesellschaft anstelle von Barverg眉tung mit 27.400 Restricted Stock Units (RSUs) beg眉nstigt. Die RSUs werden in sechs ann盲hernd gleichen monatlichen Raten ab dem 01.09.2025 verdient und unterliegen, nach dem Erwerb, einer weiteren zeitbasierten Vesting-Phase in zwei gleichen Tranchen von jeweils 13.700 Einheiten am 01.11.2025 und 01.02.2026. Bei Vesting und Abwicklung wird jede RSU in eine Stammaktie umgewandelt. Die Meldung gibt einen unmittelbaren Besitz von 159.886 Aktien unmittelbar nach der Transaktion und 29.406 Aktien, die indirekt vom Ehepartner gehalten werden, an. Die Zuteilung steht unter der Bedingung der Weiterbesch盲ftigung bis zu den relevanten Erwerbs- und Vesting-Daten.
- 27,400 RSUs awarded in lieu of cash compensation, explicitly disclosed
- Clear vesting schedule: six monthly earning installments, then two time-based vesting installments (13,700 units each)
- 1:1 conversion to common shares upon vesting, clearly stated
- None.
Insights
TL;DR: A routine equity-based compensation award replaces cash pay, aligning executive pay with shareholder interests without immediate cash outflow.
The 27,400 RSU grant awarded in lieu of cash compensation is a standard practice to preserve cash while compensating executives. The structure鈥攎onthly earning followed by two-time-based vesting installmentsprovides service retention incentives through February 1, 2026. The award converts 1:1 to common shares upon vesting, potentially increasing outstanding shares later, but no exercise price or immediate cash transaction is involved. Disclosure shows direct beneficial ownership of 159,886 shares and indirect ownership of 29,406 shares by spouse, which is material for insider holdings reporting but does not indicate any derivative positions or sales.
TL;DR: The filing documents a compensation-related equity grant with typical vesting and service conditions; disclosure is routine and transparent.
The Form 4 documents an RSU award issued under the 2015 Stock Incentive Plan, clearly describing the earning schedule and subsequent time-based vesting. The reporting person signed the filing on 08/19/2025, and the replacement of cash with equity is explicitly stated. For governance review, the filing provides required detail on timing and conversion mechanics but contains no information on board approval language or plan limits beyond the plan name; those items are not included in this Form 4.
VolitionRX Ltd. (VNRX): la reporting person Ann-Louise Batchelor ha ricevuto 27.400 unit脿 azionarie vincolate (RSU) il 15/08/2025 nell鈥檃mbito del Piano di Incentivazione Azionaria 2015 della societ脿 in sostituzione di compensi in contanti. Le RSU vengono maturate in sei rate mensili approssimativamente uguali a partire dal 01/09/2025 e, una volta maturate, sono soggette a un ulteriore periodo di vesting basato sul tempo, suddiviso in due rate uguali di 13.700 unit脿 rispettivamente il 01/11/2025 e il 01/02/2026. Al momento del vesting e del regolamento, ogni RSU si converte in una azione ordinaria. Il documento dichiara il possesso diretto di 159.886 azioni subito dopo la transazione e 29.406 azioni detenute indirettamente dal coniuge. L鈥檃ssegnazione 猫 subordinata alla prosecuzione del servizio fino alle date previste per maturazione e vesting.
VolitionRX Ltd. (VNRX): la persona informante Ann-Louise Batchelor recibi贸 27.400 unidades restringidas de acciones (RSU) el 15/08/2025 bajo el Plan de Incentivos de Acciones 2015 de la compa帽铆a, en lugar de una remuneraci贸n en efectivo. Las RSU se devengar谩n en seis cuotas mensuales aproximadamente iguales a partir del 01/09/2025 y, una vez devengadas, estar谩n sujetas a un vesting adicional por tiempo en dos cuotas iguales de 13.700 unidades el 01/11/2025 y el 01/02/2026. Al vencimiento y liquidaci贸n, cada RSU se convierte en una acci贸n ordinaria. La presentaci贸n informa la tenencia directa de 159.886 acciones inmediatamente despu茅s de la operaci贸n y 29.406 acciones mantenidas indirectamente por el c贸nyuge. La concesi贸n est谩 condicionada a la continuidad del servicio hasta las fechas de devengo y vesting aplicables.
VolitionRX Ltd. (VNRX)鞚� 氤搓碃鞛� Ann-Louise Batchelor電� 2025雲� 8鞗� 15鞚� 須岇偓鞚� 2015 欤检嫕 鞚胳劶韹半笇 頂岆灉鞐� 霐半澕 順勱笀 氤挫垬 雽�鞁� 27,400 鞝滍暅欤�(RSU)毳� 靾橃棳氚涭晿鞀惦媹雼�. 頃措嫻 RSU電� 2025雲� 9鞗� 1鞚茧秬韯� 鞎� 鞐劘 臧滌潣 霃欖澕頃� 鞗旊硠 攵勴暊搿� 旆摑霅橂┌, 旆摑 鞚错泟鞐愲姅 於旉皜鞝侅澑 旮瓣皠 旮半皹 氩犾姢韺呾澊 鞝侅毄霅橃柎 2025雲� 11鞗� 1鞚缄臣 2026雲� 2鞗� 1鞚� 臧侁皝 13,700 雼渼鞌� 霊� 氩堨棎 瓯胳硱 頇曥爼霅╇媹雼�. 氩犾姢韺� 氚� 鞝曥偘 鞁� 臧� RSU電� 氤错喌欤� 1欤茧 鞝勴櫂霅╇媹雼�. 鞝滌稖靹滊鞐愲姅 瓯半灅 歆來泟 歆侅爲 氤挫湢頃� 159,886欤�鞕� 氚办毎鞛愱皜 臧勳爲 氤挫湢頃� 29,406欤�臧� 氤搓碃霅橃柎 鞛堨姷雼堧嫟. 鞚� 靾橃棳電� 頃措嫻 旆摑 氚� 氩犾姢韺� 雮犾旯岇 瓿勳啀 攴茧頃橂姅 瓴冹潉 臁瓣贝鞙茧 頃╇媹雼�.
VolitionRX Ltd. (VNRX) : la personne d茅clarante Ann-Louise Batchelor s鈥檈st vue attribuer 27 400 unit茅s d鈥檃ctions restreintes (RSU) le 15/08/2025 dans le cadre du Plan d鈥檌ncitation en actions 2015 de la soci茅t茅, en lieu et place d鈥檜ne r茅mun茅ration en esp猫ces. Les RSU sont acquises en six versements mensuels 脿 peu pr猫s 茅gaux 脿 compter du 01/09/2025 et, une fois acquises, sont soumises 脿 un vesting suppl茅mentaire bas茅 sur la dur茅e, en deux versements 茅gaux de 13 700 unit茅s les 01/11/2025 et 01/02/2026. Lors du vesting et du r猫glement, chaque RSU se convertit en une action ordinaire. Le dossier indique une d茅tention directe de 159 886 actions imm茅diatement apr猫s la transaction et 29 406 actions d茅tenues indirectement par le conjoint. L鈥檃ttribution est conditionn茅e 脿 la poursuite du service jusqu鈥檃ux dates d鈥檃cquisition et de vesting applicables.
VolitionRX Ltd. (VNRX): Die meldende Person Ann-Louise Batchelor wurde am 15.08.2025 im Rahmen des Aktienanreizprogramms 2015 der Gesellschaft anstelle von Barverg眉tung mit 27.400 Restricted Stock Units (RSUs) beg眉nstigt. Die RSUs werden in sechs ann盲hernd gleichen monatlichen Raten ab dem 01.09.2025 verdient und unterliegen, nach dem Erwerb, einer weiteren zeitbasierten Vesting-Phase in zwei gleichen Tranchen von jeweils 13.700 Einheiten am 01.11.2025 und 01.02.2026. Bei Vesting und Abwicklung wird jede RSU in eine Stammaktie umgewandelt. Die Meldung gibt einen unmittelbaren Besitz von 159.886 Aktien unmittelbar nach der Transaktion und 29.406 Aktien, die indirekt vom Ehepartner gehalten werden, an. Die Zuteilung steht unter der Bedingung der Weiterbesch盲ftigung bis zu den relevanten Erwerbs- und Vesting-Daten.
FAQ
What did Ann-Louise Batchelor report on Form 4 for VNRX?
How and when do the 27,400 RSUs vest?
How many VNRX shares does the reporting person own after the transaction?
Will the RSUs require cash payment to realize?
Under which plan were the RSUs granted?
